HOUSTON, LONDON and RESEARCH TRIANGLE PARK, N.C., Nov. 2 /PRNewswire/ -- Fabre-Kramer Pharmaceuticals Inc. (FKP) and GlaxoSmithKline (NYSE: GSK) announced today that the U.S. Food and Drug...
PHILADELPHIA--(BUSINESS WIRE)--GlaxoSmithKline (GSK) announced today that the U.S. Food and Drug
Administration has issued an approvable letter for its topical
antibacterial, Altabax...
LONDON, PHILADELPHIA & LEXINGTON, Mass.--(BUSINESS WIRE)--GlaxoSmithKline (NYSE:GSK) and EPIX Pharmaceuticals (NASDAQ:EPIX) today
announced a worldwide multi-target strategic collaboration...
EXTON, Pa. & PHILADELPHIA--(BUSINESS WIRE)--Adolor Corporation (Nasdaq: ADLR) and GlaxoSmithKline (NYSE: GSK)
announced today that the U.S. Food and Drug Administration (FDA) has ...
--(BUSINESS WIRE)--GlaxoSmithKline [NYSE: GSK]
announced that the U.S. Food and Drug Administration (FDA) has approved
FluLaval(TM) [Influenza
Virus Vaccine] for the active...
#5: GSK News GlaxoSmithKline and Adolor Report Top-Line Results From Phase 3 Studies of Alvimopan (Entereg/Entrareg(R)); Adolor to Host an Investor Conference Call and Webcast at 8:45 am ET on Tuesday, September 5, 2006
LONDON & EXTON, Pa.--(BUSINESS WIRE)--Sept. 5, 2006--GlaxoSmithKline (LSE:GSK)(NYSE:GSK) and Adolor Corporation (Nasdaq:ADLR) today announced top-line results from two identically designed Phase 3...
LONDON, PHILADELPHIA & MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Aug. 24, 2006--GlaxoSmithKline (GSK) (NYSE:GSK) and ChemoCentryx, Inc. today announced a worldwide multi-target strategic alliance to...
--(BUSINESS WIRE)--Quitting smoking tops the list as one of the most popular New Year's resolutions made, and may be the first one broken. Nearly three out of four smokers say they would like to...
#2: GSK News Ligand Collaborator Drug Shows Encouraging Results in Thrombocytopenia; GlaxoSmithKline Releases Phase II Data; Ligand Drug for Thrombocytopenia Targeted for IND Filing 1H'06
SAN DIEGO--(BUSINESS WIRE)--Dec. 2, 2005--Ligand Pharmaceuticals Incorporated (Pink Sheets:LGND) announced today that results reported by GlaxoSmithKline (NYSE:GSK) in phase II studies of...
--(BUSINESS WIRE)--A free 2006 calendar is now available that encourages women to get in touch with their "Inner Diva" to help them take better care of their bones. Radio News Feature You can...
